This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
TheStreet Rating

10 Best Life Sciences Stocks for 2014

Top Rated Stocks

Every day TheStreet Ratings produces a list of the top rated stocks. These 10 life sciences stocks are rated highest by our methodology.

Equity Top: Life Sciences Tools & Services

Source: TheStreet Ratings

Best Investments for 2014

Life Sciences

Activist investor Alex Denner is gaining an ally on Ariad's Board.,
9/19/14 12:05PM
Trade-Ideas LLC identified AmerisourceBergen (ABC) as a strong and under the radar candidate
9/19/14 9:47AM
Shares of Repros Therapeutics (RPRX) plunged to a 52-week low Thursday after an FDA panel put up a roadblock for the company's low-testosterone drug Androxal.
9/18/14 12:34PM
Shares of Auxilium Pharmaceuticals (AUXL) were flat in morning trading Thursday despite the FDA's approval of the company's erectile dysfunction drug Stendra.
9/18/14 10:35AM
Cramer is a big fan of Cypress Semiconductor and wants you to buy, buy, buy DuPont.
9/18/14 6:00AM
Now that the Fed has done the right thing on monetary policy, investors should stop worrying and start thinking about how to make more money, Cramer says.
9/17/14 8:08PM
TheStreet highlights 3 stocks pushing the wholesale industry lower today.
9/17/14 1:04PM
The unsolicited bid comes a week after the Pennsylvania target announced a plant to cut 30% of its workforce.
9/17/14 11:50AM
The first public presentation of the GED-031 phase II data will be on Oct. 21 at a European medical conference.
9/17/14 8:26AM
CEO Schwan told Reuters that the company's decision to buy U.S. biotech company InterMune (ITMN) was "exceptional" and not a sign of more ambitious plans for major acquisitions.
9/16/14 3:02PM
On 17 occasions, RA Capital bought shares in biotech company financings after having sold short shares of the same company when it was supposed to be restricted from doing so.
9/16/14 1:04PM
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
9/16/14 12:04PM
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF where we have detected an approximate $39.2 million dollar inflow -- that's a 3.3% increase week over week in outstanding units (from 7,550,000 to 7,800,000). Among the largest underlying components of XBI, in trading today EXACT Sciences Corp.
9/16/14 10:55AM
Investors in SPDR S&P Biotech ETF saw new options become available this week, for the March 2015 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 185 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
9/16/14 10:43AM
Patients lost 12% of their body weight following 12 weeks of treatment with Arena's Belviq plus phentermine.
9/16/14 9:48AM

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 17,279.74 +13.75 0.08%
S&P 500 2,010.40 -0.96 -0.05%
NASDAQ 4,579.7890 -13.6380 -0.30%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs